CIK 0001671584 · Non-accelerated filer<br>Smaller reporting company
Aptevo Therapeutics Inc.
Sign in to watch- Ticker
- APVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811567056
- Phone
- 206-838-0500
- Business address
- 2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · Other events
- 424B4 Offering Prospectus
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
- 8-K Event Regulation FD disclosure · Other events
- 4 Option exercise SVP, GC, BD & Corp Affairs acquired 4 shares (option exercise)
- 4 Option exercise EVP, COO acquired 5 shares (option exercise)
- 4 Option exercise President and CEO acquired 14 shares (option exercise)
- 4 Option exercise SVP, CFO acquired 3 shares (option exercise)
- S-1 Offering Registration Statement
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
Page 9 of 38 · 742 filings